Asymmetric generalization between the discriminative stimulus effects of nicotine and cocaine

Behavioural Pharmacology

Volumn 10, Issue 6-7, 1999, Pages 647-656

  Desai, R I ^a   Barber, D J ^a   Terry, P ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Cocaine; Drug discrimination; Methylcarbamylcholine; Nicotine; Nornicotine; Pilocarpine; Psychostimulants; Rat

Indexed keywords

COCAINE; METHYLCARBACHOL; MUSCARINIC AGENT; NICOTINE; NICOTINIC AGENT; NORNICOTINE; PILOCARPINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; DRUG EFFECT; MALE; NONHUMAN; RAT; TRAINING;

EID: 0033375242     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-199911000-00011     Document Type: Article

References (66)

1. Ando K, Yanagita T (1978). The discriminative stimulus properties of intravenously administered cocaine in rhesus monkeys In: Stimulus Properties of Drugs: Ten Years of Progress. Colpaert FC, Rosecrans JA (editors). Amsterdam: Elsevier/North-Holland Biomedical Press, pp. 125-136.
2. Ator NA, Griffiths RR (1983). Lorazepam and pentobarbital drug discrimination in baboons: cross-drug generalization and interaction with Ro 15-1788. J Pharmacol Exp Ther 226:776-782.
3. Bardo MT, Bevins RA, Klebaur JE, Crooks PA, Dwoskin LP (1997). ( - )-Nornicotine partially substitutes for (+)-amphetamine in a drug discrimination paradigm in rats. Pharmacol Biochem Behav 58:1083-1087.
4. Barry H III, Krimmer EC (1977). Discriminable stimuli produced by alcohol and other CNS depressants. In: Discriminative Stimulus Properties of Drugs. Lal H (editor). New York: Plenum Press, pp. 73-92.
5. Boksa P, Quik M, Mitchell JB, Collier B, O'Neil W, Quirion R (1989). Pharmacological activity of N-methyl-carbamylcholine, a novel acetylcholine receptor agonist with selectivity for nicotinic receptors. Eur J Pharmacol 173:93-108.
6. Brioni JD, Kim DJB, O'Neill AB, Williams JEG, Decker MW (1994). Clozapine attenuates the discriminative stimulus properties of (-)-nicotine. Brain Res 643:1-9.
7. Brioni JD, Kim DJB, Brodie MS, Decker MW, Arneric SP (1995). ABT-418: discriminative stimulus properties and effect on ventral tegmental cell activity. Psychopharmacology 119:368-375.
8. Callahan PM, De La Garza R II, Cunningham KA (1997). Mediation of the discriminative stimulus effects of cocaine by mesocorticolimbic dopamine systems. Pharmacol Biochem Behav 57:601-607.
9. Chance WT, Murfin D, Krynock GM, Rosecrans JA (1977). A description of the nicotine stimulus and tests of its generalization to amphetamine, Psychopharmacology 55:19-26.
10. Clarke PBS, Pert CB, Pert A (1984). Autoradiographic distribution of nicotine receptors in the rat brain. Brain Res 323:390-395.
11. Consolo S, Girotti P, Russi G, Di Chiara G (1992). Endogenous dopamine facilitates striatal in vivo acetylcholine release by acting on D1 receptors localized in the striatum. J Neurochem 59:1555-1557.
12. Corrigall WA, Coen KM (1994). Dopamine mechanisms play at best a small role in the nicotine discriminative stimulus. Pharmacol Biochem Behav 48:817-820.
13. Corrigall WA, Coen KM, Adamson KL (1994). Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res 653:278-284.
14. Costanza RM, Terry P (1998). The dopamine D4 receptor antagonist L-745,870: effects in rats discriminating cocaine from saline. Eur J Pharmacol 345:129-132.
15. Day JC, Piazza PV, Le Moal M, Maccari S (1997). Cocaine-induced increase in cortical acetylcholine release: interaction with the hypothalamo-pituitary-adrenal axis. Eur J Neurosci 9:1130-1136.
16. De La Garza R, Johanson CE (1983). The discriminative stimulus properties of cocaine in the rhesus monkey. Pharmacol Biochem Behav 19:145-148.
17. De La Garza R, Johanson CE (1985). Discriminative stimulus properties of cocaine in pigeons. Psychopharmacology 85:23-30.
18. Desai RI, Barber DJ, Terry P (1998). Asymmetric generalization between the discriminative stimulus effects of nicotine and cocaine. Behav Pharmacol 9:S31.
19. Finney DJ (1964). Statistical Methods in Biological Assay, 2nd ed. New York: Hafner.
20. Gasior M, Shoaib M, Yasar S, Jaszyna M, Goldberg SR (1999). Acquisition of nicotine discrimination and discriminative stimulus effects of nicotine in rats chronically exposed to caffeine. J Pharmacol Exp Ther 288:1053-1073.
21. Gauvin DV, Carl KL, Briscoe RJ, Vallett M, Holloway FA (1995). Cross-generalization between a cocaine cue and two antihistamines. Eur J Pharmacol 294:281-288.
22. Goldberg SR, Risner ME, Stolerman IP, Reavill C, Garcha HS (1989). Nicotine and some related compounds: effects on schedule-controlled behaviour and discriminative properties in rats. Psychopharmacology 97:295-302.
23. Harland RD, Gauvin DV, Michaelis RC, Carney JM, Scale TW, Holloway FA (1989). Behavioral interaction between cocaine and caffeine: A drug discrimination analysis in rats. Pharmacol Biochem Behav 32:1017-1023.
24. Imperato A, Obinu MC, Demontis MV, Gessa GL (1992). Cocaine releases limbic acetylcholine through endogenous dopaminc action on D1 receptors. Eur J Pharmacol 229:265-267.
25. Imperato A, Obinu MC, Gessa GL (1993). Effects of cocaine and amphetamine on acetylcholine release in the hippocampus and caudate nucleus. Eur J Pharmacol 238:377-381.
26. Jones HE, Garrett BE, Griffiths RR (1999). Subjective and physiological effects of intravenous nicotine and cocaine in cigarette smoking cocaine abusers. J Pharmacol Exp Ther 288:188-197.
27. Kelley BM, Porter JH, Varvel SA (1995). Mianserin as a discriminative stimulus in rats: asymmetrical cross-generalization with scopolamine. Psychopharmacology 120:491-493.
28. Koob G (1992). Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13:177-184.
29. Kumar R, Revill C, Stolerman IP (1987). Nicotine cue in rats: effects of central administration of ganglion-blocking drugs. Br J Pharmacol 90:239-246.
30. Lal H (1977). Drug induced discriminate stimuli: past research and future perspectives. In: Discriminative Stimulus Properties of Drugs. Lal H (editor). New York: Plenum Press, pp. 207-231.
31. Mansbach RS, Rovetti CC, Freedland CS (1998). The role of monoamine neurotransmitter systems in the nicotine discriminative stimulus. Drug Alcohol Depend 52:125-134.
32. Mariathasan EA, Stolerman IP (1993). Discrimination of agonist-antagonist mixtures: experiments with nicotine plus mecamylamine. Behav Pharmacol 4:555-561.
33. Meltzer LT, Rosecrans JA (1988). Nicotine and arecoline as discriminative stimuli: Involvement of a non-cholinergic mechanism for nicotine. Pharmacol Biochem Behav 29:587-593.
34. Meltzer LT, Rosecrans JA, Aceto MD, Harris LS (1980). Discriminative stimulus properties of the optical isomers of nicotine. Psychopharmacology 68:283-286.
35. Modrow HE, Holloway FA (1994). Drug discrimination and cross generalization between two methylxanthines. Pharmacol Biochem Behav 23:425-429.
36. Morrison CF, Stephenson JA (1969). Nicotine injections as the conditioned stimulus in discrimination learning. Psychopharmacologia 15:351-360.
37. Nisell M, Nomikos GG, Svensson TH (1994a). Infusions of nicotine in the ventral tegmental area or the nucleus accumbens of the rat differentially affect accumbal dopamine release. Pharmacol Toxicol 75:348-352.
38. Nisell M, Nomikos GG, Svensson TH (1994b). Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral legmental area. Synapse 16:36-44.
39. Pich EM, Pagliusi SR, Tessari M, Talabot-Ayer D, Huijsduijnen RHV, Chiamulera C (1997). Common neural substrates for the addictive properties of nicotine and cocaine. Science 275:83-86.
40. Pontieri FE, Tanda G, Orzi F, Di Chiara G (1996). Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382:255-257.
41. Pratt JA, Stolerman IP, Garcha HS, Giardini V, Feyerabend C (1983). Discriminative stimulus properties of nicotine: Further evidence for mediation at a cholinergic receptor. Psychopharmacalogy 81:54-60.
42. Reavill C, Stolerman IP (1987). Interaction of nicotine with dopaminergic mechanisms assessed through drug discrimination and rotational behaviour in rats. J Psychopharmacol 1:264-273.
43. Romano C, Goldstein A, Jewell NP (1981). Characterization of the receptor mediating the nicotine discriminative stimulus. Psychopharmacology 74:310-315.
44. Rose JE, Sampson A, Levin ED, Henningfield JE (1989). Mecamylamine increases nicotine preference and attenuates nicotine discrimination. Pharmacol Biochem Behav 32:933-938.
45. Rosecrans JA (1995). The psychopharmacological basis of nicotine's differential effects on behaviour: Individual subject variability in the rat. Behav Genet 25:187-195.
46. Rosecrans JA, Karan LD (1993). Neurobehavioural mechanisms of nicotine action: role in the initiation and maintenanee of tobacco dependence. J Subst Abuse Treat 10:161-170.
47. Schechter MD, Meehan SM (1992). Further evidence for the mechanisms that may mediate nicotine discrimination. Pharmacol Biochem Behav 41:807-812.
48. Schechter MD, Rosecrans JA (1971). C.N.S. effects of nicotine as the discriminative stimulus for the rat in a T-maze. Life Sci 10:821-832.
49. Schechter MD, Rosecrans JA (1973). D-amphetamine as a discriminative cue: Drugs with similar stimulus properties. Eur J Pharmacol 21:212-216.
50. Shoaib M, Stolerman I P (1996). Brain sites mediating the discriminative stimulus effects of nicotine in rats. Behav Brain Res 78:183-188.
51. Snedecor GW, Cochran WG (1967). Statistical Methods, 6th ed. Ames, Iowa: Iowa State University Press.
52. Stolerman IP (1989). Discriminative stimulus effects of nicotine in rats trained under different schedules of reinforcement. Psychopharmacology 97:131-138.
53. Stolerman IP (1992). Drugs of abuse: behavioural principles, methods and terms. Trends Pharmacol Sci 13:170-177.
54. Stolerman IP, Shoaib M (1992). The neurobiology of tobacco dependence. Trends Pharmacol Sci 12:467-473.
55. Stolerman IP, Jarvis MJ (1995). The scientific case that nicotine is addictive. Psychopharmacology 117:2-10.
56. Stolerman IP, Garcha HS, Pratt JA, Kumar R (1984). Role of training dose in discrimination of nicotine and related compounds by rats. Psychopharmacology 84:413-419.
57. Stolerman IP, Rauch RJ, Norris EA (1987). Discriminative stimulus effects of a nicotine-midazolam mixture in rats. Psychopharmacology 93:250-256.
58. Stolerman IP, Mirza, NR, Shoaib M (1995). Nicotine psychopharmacology: Addiction, cognition and neuroadaptation. Med Res Rev 15:47-72.
59. Stolerman IP, Chandler CJ, Garcha HS, Newton JM (1997). Selective antagonism of behavioral effects of nicotine by dihydro-β-erythroidine in rats. Psychopharmacology 129:390-397.
60. Takada K, Swedberg MDB, Goldberg SR, Katz JL (1989). Discriminative stimulus effects of intravenous I-nicotine and nicotine analogs or metabolites in squirrel monkeys. Psychopharmacology 99:208-212.
61. Wise RA, Rompré P-P (1989). Brain dopamine and reward. Annu Rev Psychol 40:191-225.
62. Witkin JM, Nichols DE, Terry P, Katz JL (1991). Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections. J Pharmacol Exp Ther 257:706-713.
63. Wood DM, Lal H, Yaden S, Emmett-Oglesby MW (1985). One-way generalization of clonidine to the discriminative stimulus produced by cocaine. Pharmacol Biochem Behav 23:529-533.
64. Yang X, Buccafusco JJ (1994). Effect of chronic central treatment with the acetylcholine analog methylcarbamylcholine on cortical nicotinie receptors: Correlation between receptor changes and behavioral function. J Pharmacol Exp Ther 271:651-659.
65. Zernig G, O'Laughlin IA, Fibiger HC (1997). Nicotine and heroin augment cocaine-induced dopamine overflow in nucleus accumbens. Eur J Pharmacol 337:1-10.
66. Zocchi A, Pert A (1994). Alterations in striatal acetylcholine overflow by cocaine, morphine and MK-801: relationship to locomotor output. Psychopharmacology 115:297-304.